188 related articles for article (PubMed ID: 9476926)
1. Visualization of fibrous dysplasia during somatostatin receptor scintigraphy.
Chen CC; Czerwiec FS; Feuillan PP
J Nucl Med; 1998 Feb; 39(2):238-40. PubMed ID: 9476926
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin receptor scintigraphy of malignant somatostatinoma with indium-111-pentetreotide.
Schillaci O; Annibale B; Scopinaro F; delle Fave G; Colella AC
J Nucl Med; 1997 Jun; 38(6):886-7. PubMed ID: 9189135
[TBL] [Abstract][Full Text] [Related]
3. What is a false-positive somatostatin receptor scintigraphy?
Reubi JC
J Nucl Med; 1998 Dec; 39(12):2193-4. PubMed ID: 9867170
[No Abstract] [Full Text] [Related]
4. Clinical implications of somatostatin-receptor scintigraphy in ophthalmic Graves' disease.
Colao A; Pivonello R; Lastoria S; Faggiano A; Ferone D; Lombardi G; Fenzi G
Eur J Endocrinol; 2000 Oct; 143 Suppl 1():S35-42. PubMed ID: 11068938
[No Abstract] [Full Text] [Related]
5. Polyostotic fibrous dysplasia in McCune-Albright syndrome diagnosed by bone scintigraphy.
Sisayan R; Lorberboym M; Hermann G
Clin Nucl Med; 1997 Jun; 22(6):410-2. PubMed ID: 9193821
[No Abstract] [Full Text] [Related]
6. An unusual visualization of the gallbladder by somatostatin receptor (SSTR) scintigraphy: usefulness of hepatobiliary imaging for differential diagnosis.
Kurtaran A; Ofluoglu S; Traub T; Tribl B; Speiser P; Grabenwöger F; Schima W; Dudczak R; Virgolini I
Am J Gastroenterol; 2000 May; 95(5):1367-8. PubMed ID: 10811361
[No Abstract] [Full Text] [Related]
7. Hemibody uptake on bone scintigraphy in polyostotic fibrous dysplasia.
Rudenko B; Klingelschmitt S; Aubry S; Bamba M; Boulahdour H
Clin Nucl Med; 2003 Dec; 28(12):992-3. PubMed ID: 14663327
[No Abstract] [Full Text] [Related]
8. [Bone scintigraphy of the McCune-Albright syndrome].
Takeda Y; Nakagawa T; Kono R; Hiraki Y
Rinsho Hoshasen; 1989 Oct; 34(11):1409-10. PubMed ID: 2601106
[No Abstract] [Full Text] [Related]
9. Somatostatin-receptor scintigraphy in Graves' orbitopathy.
Postema PT; Kwekkeboom DJ; van Hagen PM; Krenning EP
Eur J Nucl Med; 1996 Jun; 23(6):615-7. PubMed ID: 8662098
[No Abstract] [Full Text] [Related]
10. 111In-octreotide scintigraphy in pituitary adenomas.
Tofani A; Cucchi R; Pompili A; Carapella C; Crecco M; Mottolese M; Maini CL
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):94-7. PubMed ID: 9002760
[TBL] [Abstract][Full Text] [Related]
11. McCune-Albright syndrome: the patterns of scintigraphic abnormalities.
Pfeffer S; Molina E; Feuillan P; Simon TR
J Nucl Med; 1990 Sep; 31(9):1474-8. PubMed ID: 2395015
[TBL] [Abstract][Full Text] [Related]
12. Incidental appendix carcinoid. Value of somatostatin receptor imaging.
Hoegerle S; Nitzsche EU; Stumpf A; Simon GH; Otte A; Schwarzkopf G; Moser E
Clin Nucl Med; 1997 Jul; 22(7):467-9. PubMed ID: 9227869
[TBL] [Abstract][Full Text] [Related]
13. Sarcoidosis in a clinically unaffected joint demonstrated by somatostatin receptor scintigraphy.
Kroot EJ; Dolhain RJ; van Hagen PM; Kwekkeboom DJ
Clin Nucl Med; 2006 Aug; 31(8):501-3. PubMed ID: 16855445
[No Abstract] [Full Text] [Related]
14. [McCune-Albright syndrome diagnosed by radionuclide imaging of bones].
Minamino S; Takeda K; Fujita K; Aoki H; Tsukamoto Y
Horumon To Rinsho; 1983 Jun; 31 Suppl():19-21. PubMed ID: 6616913
[No Abstract] [Full Text] [Related]
15. Alendronate and pharmacological doses of 1alpha OHD3 therapy in a patient with McCune-Albright syndrome and accompanying hypophosphatemia.
Yamamoto T; Ozono K; Shima M; Yoshikawa H; Okada S
J Bone Miner Metab; 2002; 20(3):170-3. PubMed ID: 11984700
[No Abstract] [Full Text] [Related]
16. [Scintigraphy of somatostatin receptors in the diagnosis and staging of neuroendocrine tumors of the digestive tract and pancreas].
Banzo J; Abós MD; Prats E; García F; Razola P
Rev Esp Med Nucl; 2000 Jun; 19(3):225-41. PubMed ID: 11062088
[No Abstract] [Full Text] [Related]
17. Somatostatin receptor expression in Hürthle cell cancer of the thyroid.
Gulec SA; Serafini AN; Sridhar KS; Peker KR; Gupta A; Goodwin WJ; Sfakianakis GN; Moffat FL
J Nucl Med; 1998 Feb; 39(2):243-5. PubMed ID: 9476928
[TBL] [Abstract][Full Text] [Related]
18. Receptor scintigraphy with 111In-pentetreotide for endocrine gastroenteropancreatic tumors.
Joseph K; Stapp J; Reinecke J; Skamel HJ; Höffken H; Neuhaus C; Lenze H; Trautmann ME; Arnold R
Horm Metab Res Suppl; 1993; 27():28-35. PubMed ID: 8330869
[TBL] [Abstract][Full Text] [Related]
19. Indium 111 octreotide scintigraphy in angiofibroma.
Guneri EA; Degirmenci B; Durak H; Ikiz AO; Derebek E; Sutay S
Otolaryngol Head Neck Surg; 1998 Jan; 118(1):137-9. PubMed ID: 9450844
[No Abstract] [Full Text] [Related]
20. Somatostatin receptors and breast cancer.
van Eijck CH; Kwekkeboom DJ; Krenning EP
Q J Nucl Med; 1998 Mar; 42(1):18-25. PubMed ID: 9646641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
